FMC earnings missed by $4.48, revenue fell short of estimates
FMC (NYSE: FMC) reported Q3 EPS of -$4.41, missing estimates by $4.48, with revenue at $105.6M, below the $604.67M consensus. The company expects Q4 2026 EPS of $0.56-$0.70 and revenue of $1.04B-$1.14B, both below estimates. FY 2026 EPS is forecasted at -$3.66 to -$3.50, also below expectations. The stock is down 55.65% in 3 months and 69.41% in 12 months.
How this was made
The 30-second read
Why it matters
The combination of a large EPS miss, very low reported revenue versus consensus, and FY EPS guidance far below estimates is a strong negative catalyst that can accelerate analyst downgrades and reduce valuation support.
Market read
This is a direct earnings and guidance catalyst that can drive immediate repricing and near-term positioning changes.
What to watch
Traders may focus on whether the guidance range implies a floor for losses, and whether the revenue miss reflects timing or one-off items rather than a structural demand collapse.
Background
The article is an earnings report for FMC’s third quarter, including reported EPS/revenue and forward guidance for Q4 and full-year 2026.
Ticker impact
FMC reported Q3 EPS of -$4.41 and revenue of $105.6M, both far below consensus, and guided Q4 and FY EPS below estimates.
Likely downward pressure as the market prices in materially worse FY results versus consensus.
The article provides the company’s own reported EPS/revenue misses and explicit Q4 and FY guidance that are substantially below analyst consensus, which typically triggers sustained sell-side revisions and multiple compression.
Market effects
Weak guidance from FMC can pressure sentiment toward similarly exposed industrial/chemicals names, especially those with restructuring or demand uncertainty.
Limited direct regional spillover expected beyond US small/mid-cap industrial sentiment.
Low global relevance; this is primarily company-specific earnings and guidance information.
Counterpoint
The stock is already down heavily over 3 and 12 months, so some investors may view the guidance as already discounted and look for stabilization if subsequent quarters show less deterioration.
Key entities
- companyFMC
NYSE-listed company reporting Q3 results and issuing Q4 and FY 2026 guidance.
